Wen Qing Liang
Vorstandsvorsitzender bei CF PharmTech, Inc
Profil
Wen Qing Liang is currently the Chairman & General Manager at CF PharmTech, Inc since 2020.
Prior to this, he had worked at CF PharmTech, Inc since 2013.
Dr. Liang holds a doctorate degree from the University of Massachusetts, which he received in 1996.
Aktive Positionen von Wen Qing Liang
| Unternehmen | Position | Beginn |
|---|---|---|
CF PharmTech, Inc
 CF PharmTech, Inc Medical SpecialtiesHealth Technology CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China. | Vorstandsvorsitzender | 17.09.2020 |
Ausbildung von Wen Qing Liang
| University of Massachusetts | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
CF PharmTech, Inc
CF PharmTech, Inc Medical SpecialtiesHealth Technology CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China. | Health Technology |
